Pleiotropic effects of cardilopin (secondary coronary prevention)

Georgian Medical News
|April 19, 2005
PubMed

Insights

Cardilopin (Amlodipine) treatment improved coronary atherosclerosis by restoring endothelial function and reducing platelet aggregation. This suggests benefits for heart disease patients, including those with hypertension.

Area of Science:

  • Cardiology
  • Pharmacology

Background:

  • Coronary atherosclerosis is a significant health concern.
  • Amlodipine is a commonly prescribed medication for hypertension.
  • Pleiotropic effects of Amlodipine beyond blood pressure regulation warrant investigation.

Purpose of the Study:

  • To evaluate the pleiotropic effects of Cardilopin (Amlodipine).
  • To assess Cardilopin's impact on coronary atherosclerosis parameters in ambulatory patients.

Main Methods:

  • 33 ambulatory patients were treated with Cardilopin (Amlodipine) for 2 months.
  • Key parameters of coronary atherosclerosis, endothelial function, and platelet aggregation were monitored.

Main Results:

  • Cardilopin treatment showed positive changes in coronary atherosclerosis parameters.
  • Significant improvements were observed in endothelial function and inhibition of platelet aggregation.
  • A trend towards reduced hyperlipoperoxidemia, linked to oxidative stress, was noted.

Conclusions:

  • Cardilopin (Amlodipine) exhibits beneficial pleiotropic effects in patients with coronary atherosclerosis.
  • The findings support the use of Cardilopin in coronary heart disease patients, irrespective of myocardial revascularization or arterial hypertension status.

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...